Evans WE - Search Results

1

Nomenclature for alleles of the thiopurine methyltransferase gene.

Appell ML, Berg J, Duley J, Evans WE, Kennedy MA, Lennard L, Marinaki T, McLeod HL, Relling MV, Schaeffeler E, Schwab M, Weinshilboum R, Yeoh AE, McDonagh EM, Hebert JM, Klein TE, Coulthard SA. Appell ML, et al. Among authors: evans we. Pharmacogenet Genomics. 2013 Apr;23(4):242-8. doi: 10.1097/FPC.0b013e32835f1cc0. Pharmacogenet Genomics. 2013. PMID: 23407052 Free PMC article.

2

HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy.

Dervieux T, Chu Y, Su Y, Pui CH, Evans WE, Relling MV. Dervieux T, et al. Among authors: evans we. Clin Chem. 2002 Jan;48(1):61-8. Clin Chem. 2002. PMID: 11751539

3

Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.

Panetta JC, Wall A, Pui CH, Relling MV, Evans WE. Panetta JC, et al. Among authors: evans we. Clin Cancer Res. 2002 Jul;8(7):2423-9. Clin Cancer Res. 2002. PMID: 12114448

4

Thiopurine S-methyltransferase: a genetic polymorphism that affects a small number of drugs in a big way.

Evans WE. Evans WE. Pharmacogenetics. 2002 Aug;12(6):421-3. doi: 10.1097/00008571-200208000-00001. Pharmacogenetics. 2002. PMID: 12172209 No abstract available.

5

Childhood acute lymphoblastic leukemia.

Pui CH, Relling MV, Campana D, Evans WE. Pui CH, et al. Among authors: evans we. Rev Clin Exp Hematol. 2002 Jun;6(2):161-80; discussion 200-2. doi: 10.1046/j.1468-0734.2002.00067.x. Rev Clin Exp Hematol. 2002. PMID: 12196214

6

Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.

Pui CH, Relling MV, Evans WE. Pui CH, et al. Among authors: evans we. Best Pract Res Clin Haematol. 2002 Dec;15(4):741-56. doi: 10.1053/beha.2002.0225. Best Pract Res Clin Haematol. 2002. PMID: 12617874 Review.

7

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells.

Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, Naeve CW, Relling MV, Evans WE. Cheok MH, et al. Among authors: evans we. Nat Genet. 2003 May;34(1):85-90. doi: 10.1038/ng1151. Nat Genet. 2003. PMID: 12704389

8

Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.

Dervieux T, Hancock ML, Pui CH, Rivera GK, Sandlund JT, Ribeiro RC, Boyett J, Evans WE, Relling MV. Dervieux T, et al. Among authors: evans we. Clin Pharmacol Ther. 2003 Jun;73(6):506-16. doi: 10.1016/S0009-9236(03)00063-8. Clin Pharmacol Ther. 2003. PMID: 12811360 Clinical Trial.

9

Moving towards individualized medicine with pharmacogenomics.

Evans WE, Relling MV. Evans WE, et al. Nature. 2004 May 27;429(6990):464-8. doi: 10.1038/nature02626. Nature. 2004. PMID: 15164072 Review.

10

Closing the gap between science and clinical practice: the thiopurine S-methyltransferase polymorphism moves forward.

Krynetskiy EY, Evans WE. Krynetskiy EY, et al. Among authors: evans we. Pharmacogenetics. 2004 Jul;14(7):395-6. doi: 10.1097/01.fpc.0000114753.08559.e9. Pharmacogenetics. 2004. PMID: 15226671 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

633 results

Search Page

Filters